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Skeletal muscle growth immediately following birth is
critical for proper body posture and locomotion.
However, compared with embryogenesis and adult-
hood, the processes regulating the maturation of
neonatal muscles is considerably less clear. Studies
in the 1960s predicted that neonatal muscle growth
results from nuclear accretion ofmyoblasts preferen-
tially at the tips of myofibers. Remarkably, little infor-
mation has been added since then to resolve how
myoblasts migrate to the ends of fibers. Here, we
provide insight into this process by revealing a
unique NF-kB-dependent communication between
NG2+ interstitial cells and myoblasts. NF-kB in
NG2+ cells promotes myoblast migration to the tips
of myofibers through cell-cell contact. This occurs
through expression of ephrinA5 from NG2+ cells,
which we further deduce is an NF-kB target gene.
Together, these results suggest that NF-kB plays
an important role in the development of newborn
muscles to ensure proper myoblast migration for
fiber growth.
INTRODUCTION
In humans the growth of an infant in the first 1,000 days of life is
considered vital for maximizing cognitive and behavioral func-
tion, as well as minimizing the risk of chronic diseases later in
life (Britto and Perez-Escamilla, 2013). The rate at which neo-
nates grow is higher than in any other stage of postnatal devel-
opment, and the majority of this growth, as measured in mass,
derives from skeletal muscle (Davis and Fiorotto, 2009). Surpris-
ingly, in contrast to the wealth of studies that have been devoted
to elucidating the development of skeletal muscle during
embryogenesis, and the response to injury in adults, little atten-
tion has been given to the maturation of newborn muscles.DevelopmFollowing birth, the total number of myofibers is thought to
remain fixed throughout adulthood (White et al., 2010). Rather
than adding myofibers, muscles grow longitudinally through
the accretion of myoblasts, resulting in an increasing pool of my-
onuclei that regulate the synthesis of contractile proteins and the
addition of sarcomeric units (Braun and Gautel, 2011; Ehler and
Gautel, 2008). The growth of these fibers is important to support
a musculoskeletal apparatus needed for locomotion and
posture. In mice, this post-embryonic growth phase is complete
by the third week of life (White et al., 2010). Further growth of
muscle fibers results from an increase in protein synthesis due
to the uptake of nutrients (Davis and Fiorotto, 2009). Early tracer
studies postulated that the location where myoblasts fuse along
the length of a myofiber is not a random process, but rather a co-
ordinated event occurring at the tip of the fiber (Kitiyakara and
Angevine, 1963; Williams and Goldspink, 1971). Nevertheless,
howmyoblasts from the interstitium receive their cues tomigrate
to the correct position on the fiber has yet to be identified. In
this study we describe a mechanism involving the nuclear factor
kB (NF-kB) signaling pathway and an intimate communication
between an interstitial cell population and myoblasts, which
together coordinate neonatal muscle growth.RESULTS
NF-kB Is Activated in NG2+ Cells during Neonatal Muscle
Development
We previously showed that limb muscles from newborn mice
contain a considerably high level of NF-kB activity, composed
of the classical p50 and p65 subunits in the signaling pathway
(Dahlman et al., 2010; Hayden and Ghosh, 2004, 2012). To iden-
tify a cellular source for this activity, we used reporter mice
whose EGFP expression in the cytoplasm is under the control
of an NF-kB regulated promoter (NFkB-EGFP) (Magness et al.,
2004). Results showed that NF-kB activity was localized to the
muscle interstitium and declined rapidly throughout the first
4 weeks of life, coinciding with the growth plateau phase of
neonatal limb muscles (Figure 1A). Reporter mice also revealed
that a significant portion of NF-kB activity in the extralaminarental Cell 36, 215–224, January 25, 2016 ª2016 Elsevier Inc. 215
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Figure 1. NF-kB Localizes to NG2+ Cells during Neonatal Skeletal Muscle Development
(A) Muscle sections were prepared from NFkB-EGFPmice at P7, P14, P21, and P28 for laminin staining. EGFP+ interstitial cells (ISCs) located outside of laminin
were counted per cross-sectional area and normalized to fiber numbers. ***p < 0.001.
(B) Muscle sections from P7 NFkB-EGFP mice were analyzed for Pax7 (top, red) or MyoD (bottom, red) and NF-kB (green) positive cells. Dotted white cells
represent myofiber boundaries. DAPI was used for nuclear staining.
(C) Representative images of NG2+ EGFP+ (top) and CD31+ EGFP+ cells (bottom) from the FACS analysis. Table generated from FACS analysis summarizes the
percentage of mononuclear cells from P7 NFkB-EGFP mice expressing EGFP and indicates cell surface markers used to identify cell types.
(D) Muscle sections from P7 NFkB-EGFP mice were analyzed for cell expressing both EGFP and NG2 (top) or CD31 (bottom). Dotted white cells represent
myofiber boundaries.
(E) C2C12-H2B:GFP myoblasts were co-cultured with NG2+ or CD31+ cells isolated from P2–P5 wild-type mice, and then recorded for 10 hr using time-lapse
fluorescence microscopy (top). The migration of C2C12-H2B:GFP myoblasts was measured after contacting with CD31+ or NG2+ cells, and the data are
presented as mean ± SEM. Representative still shots from the time-lapse fluorescence microscopy are shown (bottom). Arrows indicate the movements of
C2C12-H2B:GFP myoblasts.
(legend continued on next page)
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space was localized to a population distinct from Pax7+ or
MyoD+ myogenic cells (Figure 1B).
Fluorescence-activated cell sorting (FACS) analysis was used
to characterize those populations positive for NF-kB within
neonatal muscle. Results showed that a major fraction of activity
resided in both NG2+ (23.0%± 2.3%) andCD31+ (18.0%± 4.9%)
cells, with less activity present in cells positive for F4/80,
PDGFRa, or ER-TR7 markers (Figure 1C). While CD31 is present
on endothelial cells, NG2 is expressed on the surface of peri-
cytes and other cell types (Cappellari and Cossu, 2013). Immu-
nohistochemical staining of postnatal day 7 (P7) hindlimb
muscles verified that cells positive for NF-kB co-localized with
cells expressing NG2 and CD31 (Figure 1D). In neonatal muscle,
alkaline phosphatase (AP) also serves as a marker for pericytes
(Dellavalle et al., 2011). However, only a minor portion of GFP+
cells was positive for AP (<1.5%), and rarely did AP+ cells appear
in the same population as NG2+ cells (Figure S1A). In addition,
and consistent with FACS results, rarely did we observe cells
positive for both NF-kB and AP (Figure S1B). Similar results
were obtained for another pericyte marker, PDGFRb (Figure 1C).
These data demonstrate that in newborn muscle, NF-kB pre-
dominantly resides in both endothelial cells and an interstitial
NG2+ population that appears distinct from pure pericytes.
NF-kB Functions in NG2+ Cells to Promote Myoblast
Migration through Cell-Cell Contact
To investigate the functional role of CD31+ and NG2+ cells during
neonatal muscle growth, we established co-cultures of these
cells with C2C12 myoblasts stably expressing a H2B-GFP re-
porter gene. This system allowed us to monitor myoblasts over
time using fluorescent, live-cell imaging. A clear difference was
observed in the motility of myoblasts when co-cultured with
NG2+ but not CD31+ cells, which could not be accounted for
by differences in proliferation rates, as monitored by Ki67 stain-
ing (Movie S1 and Figure S1C). Co-culture studies also revealed
that NG2+ cells and myoblasts underwent cell-cell contact.
Tracking of cell movements showed that myoblasts were 33%
(p = 0.0023) more mobile in the presence of NG2+ compared
with CD31+ cells (Figure 1E), suggesting that cell-cell contact
likely contributed to the increased motility of myoblasts. Further
tracking examination revealed that following cell contact, myo-
blasts tended to migrate away from NG2+ cells (Figure 1F),
indicating that the movement of myoblasts results from con-
tact-mediated repulsion. To further assess the migration-stimu-
lating activity of NG2+ cells, we used Boyden chambers so that
C2C12-H2B:GFP myoblasts could be grown either in the same
well as NG2+ cells, or separated by a transwell filter (Figure 1F).
Compared with the migration of C2C12-H2B:GFP myoblasts
when plated by themselves (set to a value of 1), the addition of
NG2+ cells in a separate well had no effect on myoblast migra-
tion. In contrast, combining the two cell types in the same well
promotedC2C12-H2B:GFPmyoblastmigration through the filter
(Figure 1F). This strongly suggested that NG2+ cells function to(F) Migration of C2C12-H2B:GFPmyoblasts wasmonitored using a Boyden cham
or added to the upper chamber (right) at a 1:1 ratio with C2C12-H2B:GFP myobla
by themselves. Scale bars, 5 mm (B) and 10 mm (D and E).
Error bars, SEM. **p < 0.01 by Student’s t test. See also Figure S1 and Movie S1
Developmstimulate myoblast motility through cell-cell contact rather than
through a diffusible factor.
Since we found that NF-kB is active in NG2+ cells within
newbornmuscles, we next askedwhether this activity is required
for myoblast migration. Thus, co-culture assays were repeated
with C2C12-H2B:GFP myoblasts and NG2+ cells genetically
ablated for the p65 subunit of NF-kB. Results showed that myo-
blasts favored contacting p65+/+ NG2+ cells, which associated
with a 47% (p = 0.0352) increase in myoblast motility compared
with co-cultures with p65/ NG2+ cells (Movie S2 and Fig-
ure 2A). To substantiate these results, we performed a separate
migration assay using a two-chamber system, which, as illus-
trated in Figure 2B, allows the simultaneous culture of two
distinct cell populations in the same culture dish. Unlabeled
C2C12myoblasts were plated in one chamber and subsequently
differentiated into myotubes prior to plating a mixture of
C2C12-H2B:GFP myoblasts with p65+/+ or p65/ NG2+ cells
in the opposite chamber. Following the removal of a gasket
separating the chambers, we quantitated the number of
C2C12-H2B:GFP myoblasts that migrated across the gap in
the direction of differentiated myotubes. Results showed that
myoblast migration was considerably increased by 209% (p =
0.00683) in the presence of p65+/+ NG2+ cells compared with
p65/ NG2+ cells (Figure 2B and Movie S3). This regulation
was selective to the p65 subunit, since similar differences in
myoblast migration were not observed between p50+/+ and
p50/NG2+ cultures (Figure S2A). We also found that migration
was more efficient when myoblasts were exposed to myotubes
rather than an empty chamber (Figure S2B), consistent with
the notion that myotubes secrete chemotactic factors to stimu-
late myoblast motility (Griffin et al., 2010). We previously demon-
strated that p65 regulation of the inducible nitric oxide synthase
gene (iNOS) and secretion of nitric oxide (NO) from stromal
fibroblasts promotes myoblast nuclear accretion to myofibers
(Dahlman et al., 2010). To determine whether this regulation
was also relevant in myoblast migration, we repeated migration
assays in the presence of NO. However, neither the NO donor,
sodium nitroprusside, or iNOS/ NG2+ cells had a significant
effect on the migration of C2C12-H2B:GFP myoblasts, suggest-
ing that p65 regulation of iNOS is not involved in mobilizing skel-
etal muscle cells (Figures S2C and S2D).
NF-kB Functions in NG2+ Cells to Promote Myoblast
Migration In Vivo
Next, we asked whether NF-kB controls myoblast migration
in vivo. Mice containing an CreERT2 allele under the control of
the NG2 promoter were crossed with p65flox/flox (p65fl/fl) mice
(Steinbrecher et al., 2008). Resulting progenies with genotypes
NG2CreER;p65+/+ and NG2CreER;p65fl/fl were administered
tamoxifen at P2 to induce Cre-mediated deletion of p65 in
NG2 cells. Hindlimb muscles were subsequently analyzed at
P30, when postnatal muscle development is stabilized. No differ-
ences were observed in myofiber number per area (Figure S2E).ber systemwhere NG2+ cells were plated either in the lower chamber alone (left)
sts. Relative migration was normalized to C2C12-H2B:GFP myoblast migration
.
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Figure 2. The p65 Activity of NF-kB Functions in NG2 Cells to Promote Myoblast Migration In Vitro and In Vivo
(A) Plots of time-lapse microscopy, recording the migration of C2C12-H2B:GFP myoblasts cultured alone, or with either p65+/+ NG2+ or p65/ NG2+ cells. The
migration of C2C12-H2B:GFP myoblasts was measured following their contact with p65+/+ or p65/ NG2+ cells. Values are presented as mean ± SEM.
(B) Two-chambermigration system showing differentiated C2C12myotubes (red) on the right side of the chamber and C2C12-H2B:GFPmyoblasts (green) on the
left side, cultured either alone, with p65+/+ NG2+ cells, or with p65/ NG2+ cells. Upon removal of the gasket, C2C12-H2B:GFP myoblasts migrate toward
(legend continued on next page)
218 Developmental Cell 36, 215–224, January 25, 2016 ª2016 Elsevier Inc.
However, we noted that the number of myonuclei per fiber were
significantly reduced inNG2CreER;p65fl/flmice, coinciding with an
increase in the number of cells residing in the muscle interstitium
(Figures 2C and 2D). In addition, we observed an unusual hetero-
geneity in myofiber size in NG2CreER;p65fl/fl mice compared with
NG2CreER;p65+/+ mice (Figure 2E).
These results are consistent with our in vitro data supporting
the hypothesis that p65 functions in NG2+ cells to regulate
migration of myoblasts to their target myofibers. We then per-
formed an in vivo myoblast migration assay adopted from earlier
studies. This technique depends on DNA analogs to track
dividing cells in newborn muscles, and was originally used to
demonstrate that the accretion of myoblasts to growing myofib-
ers preferentially occurs at the ends of the fibers (Kitiyakara and
Angevine, 1963; Williams and Goldspink, 1971). As illustrated in
Figure 2F, when this approach was performed by pulsing hin-
dlimbs of P2 mice with the thymidine analog 5-bromo-2-deoxy-
uridine (BrdU), the position of BrdU+ nuclei in extensor digitorum
longus (EDL) muscles could be tracked over time due to the
sequential accretion of unlabeled myoblasts. For example, by
serial cross-section and whole-mount analysis of EDL muscles,
BrdU+ myonuclei were positioned closer to the midline at P21
than at P14 (Figure S2F), which supports the model that the
fusion of myoblasts to a growing myofiber is coordinated in a
spatial rather than in a random process. We proceeded to use
the same labeling strategy with P2 NG2CreER;p65+/+ and
NG2CreER;p65fl/fl mice injected with BrdU and tamoxifen. BrdU+
myonuclei were subsequently scored fromEDLmuscle sections.
Results showed that the number of BrdU+ myonuclei localized
at the midline of EDL muscles was significantly reduced
by 87% (p = 0.00533) in NG2CreER;p65fl/fl compared with
NG2CreER;p65+/+ mice (Figures 2G, 2H, and S2G). Whole-mount
muscle analysis showed that this difference was not due to any
changes to the position of NG2+ cells along the length of the my-
ofiber resulting from p65 deletion (Figure S2H). Taking into ac-
count both in vitro and in vivo results, these findings strongly
support the notion that in newborn muscles, NF-kB functions
in NG2+ cells to stimulate the migration of myoblasts to the
tips of myofibers for accretion to occur.
EFNA5 Is Directly Regulated by NF-kB Signaling
To gain insight into the mechanism by which NF-kB functions in
this capacity, we performed genome-wide expression profiling
using microarray and RNA-sequencing (RNA-seq) analyses
from early (P2), mid (P7), and late (P14) time points of neonatal
muscle development. Annotation from both methods revealedmyotubes and cell number is scored across the gap at 24 hr. Relative migration w
for troponin T.
(C) Myonuclei number per fiber was measured from quadriceps (Quad), gastrocn
and NG2CreER;p65fl/fl mice. Approximately 800 myonuclei for each genotype wer
(D) DAPI+ interstitial cells (ISCs) were measured from Quad, Gas, and TA muscle
(E) (Top) Representative cross sections of Gas from P30 NG2CreER;p65+/+ and NG
(Bottom) Quantitative distribution of fiber size from NG2CreER;p65+/+ and NG2Cre
(F) Schematic of BrdU injection experiment where BrdU+ cells are depicted with
(G) BrdU was injected in P2 NG2CreER;p65+/+ and NG2CreER;p65fl/flmice, and at P3
cells per myofiber, measured at the midline of the muscle.
(H) A model for BrdU+ cell accretion in EDL muscles from NG2CreER;p65+/+ and N
Scale bars, 100 mm for (B) and (E). *p < 0.05, **p < 0.01 by Student’s t test.
Error bars, SEM. See also Figure S2, Movies S2, and S3.
Developmthe predicted regulatory expression changes in fetal and
neonatal myosin genes (Figures S3A and S3B). We then mined
for candidate genes involved in cell migration whose protein
function is dependent on cell-cell contact. One class of genes
that fit this criterion was the Eph/Ephrin receptor tyrosine kinase
family, which function by transmitting their signals between
ligand (Ephrin) and receptor (Eph) to promote directional migra-
tion (Petrie et al., 2009; Poliakov et al., 2004). Interestingly,
several Eph/Ephrin members have been described to regulate
skeletal muscle progenitor cell motility (Li and Johnson, 2013;
Siegel et al., 2009; Stark et al., 2011; Swartz et al., 2001). Both
microarray and RNA-seq revealed that several of the Eph/Ephrin
genes (EFNA2, EFNA4, EFNA5, EFNB1) were downregulated in
hindlimb muscles during the first 2 weeks of life, results that
we validated by qRT-PCR analysis (Figure 3A). Since this gene
expression pattern was consistent with what we had earlier
observed for NF-kB activity (Figure 1A), we considered that
Eph/Ephrin genes might be transcriptional targets of NF-kB.
We therefore used the rVista database to query Eph/Ephrin pro-
moters for potential NF-kB regulatory elements. One gene,
EFNA5, contained conserved NF-kB binding sites at positions
2969, 1480, and +163, relative to the transcriptional start
site (Figure 3B). Chromatin immunoprecipitation experiments in
NG2+ cells confirmed the binding of p65 to each of these sites,
which were enriched in response to an NF-kB inducer (inter-
leukin-1b [IL-1b], Figure 3C). Similar binding of p65 to EFNA5
was observed in p65+/+ mouse embryonic fibroblasts (MEFs),
which as expected was pronouncedly reduced in p65/ cells
(Figure 3D). We next tested the functionality of this site by gener-
ating a luciferase reporter construct containing the wild-type and
mutated version of the +163 NF-kB binding site. Results showed
that the EFNA5 reporter was active in MEFs, but this activity was
significantly diminished when assays were repeated with a
mutated NF-kB binding site (Figure 3E). Such results provided
evidence that the EFNA5 gene is a direct target of NF-kB. For
further validation, we tested the expression of EFNA5 in NG2+
cells by FACS analysis. EFNA5 expression was significantly
reduced in p65/ compared with p65+/+ NG2+ cells (Figure 3F).
Similar results were obtained with p65+/+ and p65/ MEFs (Fig-
ure S3C), which together demonstrated that expression of
EFNA5 in neonatal muscle is under NF-kB control.
EphrinA5 Is a Regulator of Myoblast Migration
Next, we assessed the functional relevance of EFNA5 in
myoblast migration by using a Boyden chamber assay. C2C12
myoblasts were cultured in the upper well and subsequentlyas expressed as mean ± SEM. Myotubes were visualized by immunostaining
emius muscles (Gas), and tibialis anterior (TA) muscles from NG2CreER;p65+/+
e analyzed.
s from P30 NG2CreER;p65+/+ and NG2CreER;p65fl/fl mice.
2CreER;p65fl/fl mice immunostained for laminin and counterstained with DAPI.
ER;p65fl/fl mice recorded from a minimum of 1,000 fibers.
yellow nuclei.
0 EDL muscle sections were analyzed for the sublaminar localization of BrdU+
G2CreER;p65fl/fl mice.
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Figure 3. EFNA5 Is Transcriptionally Regulated by NF-kB
(A) Microarray, RNA-seq, and quantitative RT-PCR were performed to probe for the expression of ephrin genes from skeletal muscles at P2, P7, and P14.
(B) A schematic map of the 50 region of the EFNA5 gene and locations of conserved NF-kB DNA binding sites at 2969, 1480, and +163 relative to the
transcriptional start site.
(C) ChIP assays for p65 binding to the EFNA5 promoter in NG2+ cells untreated and treated with 10 ng/ml of IL-1b.
(D) ChIP assays for p65 binding to the EFNA5 promoter in p65+/+ MEFs untreated and treated with 10 ng/ml of IL-1b, compared with untreated p65/ MEFs.
***p < 0.001.
(E) A portion of EFNA5 gene containing the +163 binding site of NF-kBwas cloned into a luciferase reporter construct. Luciferase activity wasmeasured following
the transfection of an EFNA5 promoter reporter construct in MEFs, and compared with activity generated from an EFNA5 promoter reporter construct containing
a mutation in the +163 NF-kB binding site.
(F) (Top) Representative flow images of ephrinA5 from p65+/+ and p65/ NG2 cells. (Bottom) Percentage of ephrinA5high NG2 cells isolated from p65+/+ and
p65/ cells. RLU, relative luciferase units; B/F, bright-field image.
*p < 0.05, **p < 0.01, ***p < 0.001 by Student’s t test. Error bars, SEM.
See also Figure S3.treated with eight different types of recombinant Fc-clustered
ephrin ligands (ephrinA1–A5 and ephrinB1–B3). Whereas some
myoblast migratory activity was observed from ephrinA1-Fc
and A2-Fc, the greatest stimulation came from ephrinA5-Fc (Fig-
ure 4A). To confirm this specificity to EFNA5, we co-cultured
C2C12-H2B:GFPmyoblasts with MEFs that had been previously220 Developmental Cell 36, 215–224, January 25, 2016 ª2016 Elsevitransfected with a small interfering RNA (siRNA) against
EFNA5 (Figure S4A), and myoblast migration was monitored
in a two-chamber migration system as described in Figure 2.
Knockdown of EFNA5, but not siControl or an siRNA against
EFNB1, caused a significant reduction in myoblast motility
(Figures 4B and S4B).er Inc.
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Figure 4. EFNA5 from NG2+ Cells Mediates Myoblast Migration In Vitro and In Vivo
(A) A Boyden chamber was used to measure migration of myoblasts when exposed for 24 hr to different recombinant Fc-clustered ephrins.
(B) A two-chamber assay system was used to measure migration of C2C12-H2B:GFP myoblasts toward myotubes when co-cultured with MEFs transfected
with siRNAs against EFNA5 or EFNB1. Relative migration is shown as mean ± SEM. Scale bar, 100 mm.
(C and D) Myonuclei number per fiber (C) and DAPI+ ISCs (D) was measured from Quad, Gas, and TA muscles from P30 NG2CreER;EFNA5+/+ and
NG2CreER;EFNA5fl/fl mice.
(E) BrdU was injected in NG2CreER;EFNA5+/+ and NG2CreER;EFNA5fl/fl mice, and at P30 muscle sections were analyzed for the sublaminar localization of BrdU+
cells at the midline of EDL muscles.
(F) A model for BrdU+ cell accretion in muscles from NG2CreER;EFNA5+/+ and NG2CreER;EFNA5fl/fl mice.
*p < 0.05, ***p < 0.001 by Student’s t test. Error bars, SEM. See also Figure S4.To determine whether a similar function for EFNA5 could be
recapitulated in vivo, we generated conditional mutant mice
using a targeting vector where exon 2 of EFNA5 was flanked
by flox alleles (Figure S4C). These mice were crossed with
NG2CreERT2 mice to generate NG2CreER;EFNA5fl/fl progeny. P2Developmneonates were treated with tamoxifen to cause deletion of
EFNA5 from NG2+ cells (Figure S4D), and hindlimb muscles
were subsequently examined histologically at P30. Similarly to
the muscle phenotypes of NG2CreER;p65fl/fl, loss of EFNA5 had
no effect on myofiber number or the position of NG2+ cells alongental Cell 36, 215–224, January 25, 2016 ª2016 Elsevier Inc. 221
themyofiber (Figures S4E andS4G), but did lead to a reduction in
myonuclei number per fiber from multiple muscles, which was
inversely correlated with an increase in interstitial nuclei (Figures
4C and 4D). To examine the ability of EFNA5 to aid in myoblast
migration, we simultaneously pulsed hindlimb muscles from
NG2CreER;EFNA5fl/flmicewith BrdU and tamoxifen. EDL sections
were prepared, and the position of BrdU+ myonuclei was then
scored along the length of the muscle. The number of BrdU+ my-
onuclei localized at the midline of EDL muscles was significantly
reduced, by 88% (p = 0.07 3 104) in NG2CreER;EFNA5fl/fl
compared with NG2CreER;EFNA5+/+ mice (Figures 4E and 4F).
These findings phenocopy results obtained in p65/ NG2+ cells
and suggest that EFNA5 plays an important role in guiding the
migration of myoblasts to the ends of growing myofibers. How-
ever, unlike NG2CreER;p65fl/fl mice, loss of EFNA5 only trended
to showing differences in the distribution of fiber diameter size
(Figure S4F). Together, these results suggest that EFNA5 is
involved in regulating myoblast migration during neonatal mus-
cle growth.
DISCUSSION
In this study, we explored the underlying mechanism by which
myoblasts migrate to their targeted myofibers. Our results re-
vealed the involvement of an NF-kB signaling pathway func-
tioning in an NG2+ interstitial cell population. NF-kB is activated
in these cells early in neonatal muscle development. Through its
regulation of the ligand ephrinA5, NG2+ cells contact and stimu-
late myoblasts to migrate toward the end of growing myofibers,
where they subsequently fuse, thus providing an increased pool
of myonuclei. In support of this notion, both deletion of p65 and
EFNA5 from NG2+ cells led to an increase in the number of inter-
stitial cells and a reduction in myonuclei compared with wild-
type mice. However, we noted that this phenotype did not occur
to the same degree in all hindlimb muscles that we examined.
This might be due to differences that occur when migration
and accretion of myoblasts are at their maximum, or the ability
of specific muscles to compensate for growth defects during
neonatal development. It is also possible that, failing to migrate
to their proper location due to impaired signaling from NG2+
cells, myoblasts may undergo a default pathway such as
apoptosis leading to their turnover, which would affect their total
numbers in the interstitium.We also observed that loss of EFNA5
in NG2+ cells did not affect the distribution of fiber size to the
same extent as when p65 was deleted from these same cells.
Although it is possible that a difference in recombination effi-
ciency of flox sites between p65 and EFNA5 alleles accounted
for this variance, it is equally probable that, in addition to
EFNA5, other NF-kB gene targets in NG2+ cells are utilized to
communicate with myoblasts and contribute in muscle growth.
Relatively little is known as yet with regard to how myoblasts
migrate. Global deletion of scatter factor/hepatocyte growth fac-
tor (SC/HGF) had originally been shown to cause a defect in the
growth of developing limbs due to a failure in the migration of
progenitor myoblasts (Bladt et al., 1995). A further role for the
HGF/c-MET axis has been studied in adult muscles undergoing
regeneration (Webster and Fan, 2013), but whether this ligand-
receptor signaling pathway functions in newborn muscles to
stimulate myoblast proliferation or migration is not known. Addi-222 Developmental Cell 36, 215–224, January 25, 2016 ª2016 Elsevitional factors, CXCL12 and odorant receptor MOR23, have also
been shown to contribute to myoblast migration during in vitro
myogenesis and adult muscle regeneration (Griffin et al., 2009,
2010), but whether their activities are relevant in promoting myo-
blasts to the ends of growing fibers in newborn muscles will
require additional investigation.
Ephrins/Eph signaling has previously been described in the
regulation of axonal guidance, blood vessel formation, and
neuromuscular junction maturation (Klein, 2012; Yumoto et al.,
2008). Their expression has also been detected in normal and
regenerating muscles, and selective ephrins have been shown
to stimulate myoblast migration in vitro (Stark et al., 2011). How-
ever, in all of these instances the upstream factors regulating
Ephrin/Eph production have not been identified, nor has the
in vivo context in which Ephrin/Eph signals regulate myoblasts
or other cell types in skeletal muscle been resolved. Our findings
demonstrate that one such upstream regulator is NF-kB, which
functions as a direct transcriptional activator of EFNA5. Using
a series of cell-based and genetic approaches inmice, we further
revealed that ephrinA5 expression in NG2+ interstitial cells is
necessary to promote cell-cell contact with myoblasts, which
in turn stimulated myoblast migration. Because we found that
NG2+ cells are positioned along the length of a myofiber, whose
locations were unaffected by the loss of p65 or ephrinA5, we
envision that movement of myoblasts is likely to require multiple
interactions with NG2+ cells to reach the end of a developing fi-
ber in newborn mice. The source of these myoblasts is currently
unclear, but our results show that sublaminar Pax7+ cells stain
positive for the proliferation marker Ki67 (Figure S4H), sugges-
tive of activated satellite cells. Further immunohistochemical
co-staining with dystrophin and laminin confirmed that such
activation occurs within the niche where satellite cells reside
(Figure S4I). These results indicate that during neonatal muscle
growth, satellite cells represent at least one cell type that contrib-
utes to the myoblast pool involved in migration and fusion to
growing myofibers.
As opposed to adult muscle injury where macrophages and
resident mesenchymal progenitor cells have been shown to
contribute to a pro-regenerative response (Deng et al., 2012;
Joe et al., 2010), the role that stromal cells play in regulating
the growth of newborn muscles has been much less appreci-
ated. Only recently has a population of connective tissue fibro-
blasts expressing the transcription factor, Tcf4, been linked to
thematuration of neonatal muscle by regulating the specification
of fiber type, potentially through a secreted factor whose cell of
origin remains to be elucidated (Mathew et al., 2011). Our current
work adds to the unique role of a muscle interstitial cell popula-
tion whose communication with myoblasts plays a key role in
neonatal muscle growth.EXPERIMENTAL PROCEDURES
Mice
All animals were housed, maintained, and used according to protocols
approved by the Institutional Animal Care and Use Committees at the Ohio
State University. NF-kBEGFP/+, Rosa26-Tomato, iNOS/, NG2CreER, and
p50/ mice were purchased from Jackson Laboratories. p65/;TNFRa/,
and p65fl/fl mice were generated as previously described (Doi et al., 1999;
Steinbrecher et al., 2008). The EFNA5 cKO (Efna5fl/fl) mouse was generated
using standard embryonic stem cell technology (Tessarollo et al., 2009).er Inc.
The targeting vector was obtained from the International Mouse Knockout
Consortium (IKMC). Correctly recombined ES cells were identified by southern
analysis. Germline transmission of the targeted allele (IKMC tm1a allele) was
assessed by PCR according to IKMC guidelines. Before use for indicated ex-
periments, Efna5tm1a/+ mice were bred to a ubiquitous Flpe strain (Jackson
Laboratories). In the Efna5tm1c/+ (Efna5fl/+) mice, excision of the IRES-LacZ-
neo cassette was verified by PCR using the suggested IKMC primers.
NG2CreER mice (Jackson Laboratories) were crossed with p65fl/fl or EFNAfl/fl
to delete p65 or EFNA5 in NG2+ cells. To induce recombination in early
neonatal development, we injected tamoxifen (0.2 mg/pup) dissolved in corn
oil subcutaneously to mice on P2.
Immunofluorescence Staining
Muscle tissueswere snap-frozenwithOCTmedium inmethyl-butane solutions
chilled in liquid nitrogen. To freeze muscle containing EGFP or Tomato re-
porter, we prefixed muscle tissues with 4% paraformaldehyde overnight at
4C followed by a 48-hr incubation with 30% sucrose at 4C. For EGFP+ inter-
stitial cell analysis, whole hindlimbs were used from P7 mice, otherwise Quad
and Gas muscles were used from mice at P14 or older. 10-mm sections were
obtained for all staining experiments except for myonuclei number/fiber count-
ing using 30-mm-thick sections. Sections were air-dried and incubated with
4%paraformaldehyde for fixation at room temperature, followed by incubation
with blocking buffer containing 5% goat serum and 0.2% Triton X-100 for
30 min at room temperature. Primary antibodies anti-NG2 (Millipore), anti-
CD31 (BD Pharmingen), anti-a laminin (Sigma), and anti-MyoD (Dako) were
diluted in blocking buffer and incubated for 1 hr at room temperature. For
MyoD, the primary antibody was incubated overnight at 4C. After washing
three times with PBS, fluorescent-conjugated secondary antibodies (Invitro-
gen) were incubated for 1 hr at room temperature. The slides were rinsed
with PBS and stained with DAPI solutions. For adherent cell staining, culture
plates were washed with PBS and directly fixed with 4% paraformaldehyde.
Anti-ki67 (Dako) and anti-troponin T (Sigma) were used as primary antibodies
following the same procedure as described for tissue sections. The images
were obtained with either an Olympus FV 1000 Spectral or filter confocal laser
microscope, and analyzed by ImageJ and FV10-ASW 4.0 viewer. At least three
mice were analyzed for each staining.
Statistical Analysis
All quantitative data are shown as themean ± SEM. All statistical analysis were
performed using a two-tailed unpaired Student’s t test (*p < 0.05, **p < 0.01,
***p < 0.001 on figures).
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